Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Sweat Proteomics in Cystic Fibrosis: Discovering Companion Biomarkers for Precision Medicine and Therapeutic Development

31 Jul 2022

Abstract excerpt

genotyping, and CFTR functional testing, a small fraction (1-2%) of inconclusive diagnoses are reported and justifies the search for new CF biomarkers. More importantly, in the context of precision medicine, with a view to early diagnosis, better prognosis, appropriate clinical follow-up, and new therapeutic development, discovering companion biomarkers of CF severity and phenotypic rescue are of utmost interest....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cystic Fibrosis Research Advances
Share to Inhalation and Respiratory Drug Delivery
Share to Neonatal Respiratory Health Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35954202
DOI: 10.3390/cells11152358

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Sweat Proteomics in Cystic Fibrosis: Discovering Companion Biomarkers for Precision Medicine and Therapeutic DevelopmentPMID 35954202Read ↗

Characterization of the Human Eccrine Sweat Proteome—A Focus on the Biological Variability of Individual Sweat Protein ProfilesSemantic proximity Read ↗

Cystic Fibrosis: Modern Diagnostic and Therapeutic Advances from Molecular Pathogenesis to Multidisciplinary Management.Semantic proximity Read ↗

Serum Exosomal Multi-Omic Signatures Stratify Glucose Tolerance in Cystic Fibrosis and Reveal Partial Therapeutic Reprogramming by CFTR ModulatorsSemantic proximity Read ↗

Towards the pharmacogenomics of cystic fibrosis.Semantic proximity Read ↗

Proteomics and Metabolomics for Cystic Fibrosis Research.Semantic proximity Read ↗

Human Sputum Proteomics: Advancing Non-Invasive Diagnosis of Respiratory Diseases with Enhanced Biomarker Analysis MethodsSemantic proximity Read ↗

Effects of ivacaftor on systemic inflammation and the plasma proteome in people with CF and G551D.Semantic proximity Read ↗

Proteomic Analysis of Human Sputum for the Diagnosis of Lung Disorders: Where Are We Today?Semantic proximity Read ↗

Skin biomarkers for cystic fibrosis: a potential noninvasive approach for patient screeningSemantic proximity Read ↗

Reconsidering the diagnosis: Abnormal sweat chloride tests in non-CF bronchiectasisSemantic proximity Read ↗

Dried blood spot proteomics as a diagnostic framework for citrin deficiencySemantic proximity Read ↗

Extracellular Vesicles’ Role in the Pathophysiology and as Biomarkers in Cystic Fibrosis and COPDSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.